GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » EPS without NRI

Tchaikapharma Highquality Medicines AD (XBUL:THQM) EPS without NRI : лв0.05 (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Tchaikapharma Highquality Medicines AD EPS without NRI?

Tchaikapharma Highquality Medicines AD's earnings per share without non-recurring items for the three months ended in Dec. 2024 was лв0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was лв0.05.

During the past 12 months, Tchaikapharma Highquality Medicines AD's average earnings per share (NRI) Growth Rate was 25.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 38.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 27.20% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Tchaikapharma Highquality Medicines AD's EPS without NRI or its related term are showing as below:

XBUL:THQM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -61.4   Med: -17.85   Max: 78.8
Current: 38.1

During the past 9 years, Tchaikapharma Highquality Medicines AD's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 78.80% per year. The lowest was -61.40% per year. And the median was -17.85% per year.

XBUL:THQM's 3-Year EPS without NRI Growth Rate is ranked better than
81.28% of 812 companies
in the Drug Manufacturers industry
Industry Median: 8.25 vs XBUL:THQM: 38.10

Tchaikapharma Highquality Medicines AD's EPS (Diluted) for the three months ended in Dec. 2024 was лв0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was лв0.05.

Tchaikapharma Highquality Medicines AD's EPS (Basic) for the three months ended in Dec. 2024 was лв0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was лв0.05.


Tchaikapharma Highquality Medicines AD EPS without NRI Historical Data

The historical data trend for Tchaikapharma Highquality Medicines AD's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tchaikapharma Highquality Medicines AD EPS without NRI Chart

Tchaikapharma Highquality Medicines AD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only 0.01 0.02 0.03 0.04 0.05

Tchaikapharma Highquality Medicines AD Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.02 0.01 0.02 -

Competitive Comparison of Tchaikapharma Highquality Medicines AD's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, Tchaikapharma Highquality Medicines AD's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tchaikapharma Highquality Medicines AD's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tchaikapharma Highquality Medicines AD's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Tchaikapharma Highquality Medicines AD's PE Ratio without NRI falls into.


;
;

Tchaikapharma Highquality Medicines AD EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tchaikapharma Highquality Medicines AD  (XBUL:THQM) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Tchaikapharma Highquality Medicines AD EPS without NRI Related Terms

Thank you for viewing the detailed overview of Tchaikapharma Highquality Medicines AD's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Tchaikapharma Highquality Medicines AD Business Description

Traded in Other Exchanges
N/A
Address
1 G. M. Dimitrov Boulevard, Sofia, BGR, 1172
Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. It manufactures medicines for cancer, heart diseases, respiratory problems, and neurological diseases, among others.

Tchaikapharma Highquality Medicines AD Headlines

No Headlines